Cargando…
Mesenchymal Stem Cells (MSCs): A Novel Therapy for Type 2 Diabetes
Although plenty of drugs are currently available for type 2 diabetes mellitus (T2DM), a subset of patients still failed to restore normoglycemia. Recent studies proved that symptoms of T2DM patients who are unresponsive to conventional medications could be relieved with mesenchymal stem/stromal cell...
Autores principales: | Gao, Shuang, Zhang, Yuanyuan, Liang, Kaini, Bi, Ran, Du, Yanan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424025/ https://www.ncbi.nlm.nih.gov/pubmed/36045953 http://dx.doi.org/10.1155/2022/8637493 |
Ejemplares similares
-
Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs
por: Weiss, Andreas Robert Rudolf, et al.
Publicado: (2019) -
Injectable bone marrow microniches by co-culture of HSPCs with MSCs in 3D microscaffolds promote hematopoietic reconstitution from acute lethal radiation
por: Liang, Haiwei, et al.
Publicado: (2022) -
Regenerative Potential of Mesenchymal Stem Cells’ (MSCs) Secretome for Liver Fibrosis Therapies
por: Nazarie (Ignat), Simona-Rebeca, et al.
Publicado: (2021) -
The developmental basis of mesenchymal stem/stromal cells (MSCs)
por: Sheng, Guojun
Publicado: (2015) -
Mesenchymal stem cells (MSCs) as skeletal therapeutics–an update
por: Saeed, Hamid, et al.
Publicado: (2016)